ASX Announcement

CLINUVEL starts global Phase III vitiligo study

Published: 18/10/23, 10:08am (AEST)4 pages
Clinuvel Pharmaceuticals Limited
CUV:ASXHealthcare

Recent CUV Announcements

Price Sensitive only